JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD𝟖⁺ T Cells in Renal Cell Carcinoma Patients

Figure 4

Characterization of the T_EMRA population in RCC patients. Based on CD28/CD27 expression, CD8⁺ T cells were separated into three distinct populations: pE1 (RA⁺CCR7^-27⁺28⁺), pE2 (RA⁺CCR7^-27⁺28⁻), and E (RA⁺CCR7^-27^-28- ). Results are depicted for patients RCC2 but are representative of all 5 RCC patients evaluated.

(a)

(b)

(c)

(d)